Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration.
“Cannabinoids have been demonstrated to exert neuroprotective effects on different types of neuronal insults.
Here we have addressed the therapeutic potential of the synthetic cannabinoid HU210 on photoreceptor degeneration, synaptic connectivity and functional activity of the retina in the transgenic P23H rat, an animal model for autosomal dominant retinitis pigmentosa (RP)…
These data suggest that cannabinoids are potentially useful to delay retinal degeneration in RP patients.”
This Research and Resources page is sponsored by the Ohio Rights Group Education Fund.
Please support our charitable and educational work by making a generous tax deductible donation.